ANGLE plc (LON:AGL – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 2.35 and traded as low as GBX 2.33. ANGLE shares last traded at GBX 2.35, with a volume of 1,682,496 shares.
ANGLE Stock Performance
The stock has a market capitalization of £7.58 million, a price-to-earnings ratio of -0.49 and a beta of 0.22. The company has a current ratio of 5.19, a quick ratio of 6.18 and a debt-to-equity ratio of 17.22. The firm has a 50-day moving average of GBX 2.35 and a 200-day moving average of GBX 3.30.
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Further Reading
- Five stocks we like better than ANGLE
- The buying spree that no one is talking about
- How to collect $500-$800 weekly (BlackRock’s system)
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- They just tried to kill gold
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
